{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T19:42:30Z","timestamp":1788896550383,"version":"build-2803163510"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1097\/dad.0b013e3181cb3ff7","type":"journal-article","created":{"date-parts":[[2010,6,2]],"date-time":"2010-06-02T14:53:34Z","timestamp":1275490414000},"page":"568-573","source":"Crossref","is-referenced-by-count":56,"title":["Histopathologic Spectrum of Psoriasiform Skin Reactions Associated With Tumor Necrosis Factor-\u03b1 Inhibitor Therapy. A Study of 16 Biopsies"],"prefix":"10.1097","volume":"32","author":[{"given":"Alvaro C","family":"Laga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth A","family":"Vleugels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abrar A","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsa F","family":"Velazquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00128071-200809010-00001","article-title":"Tumor necrosis factor- inhibitor-induced psoriasis or psoriasiform exanthemata. First 120 cases from the literature including a series of six new patients.","volume":"9","author":"Wollina","year":"2008","journal-title":"Am J Clin Dermatol"},{"key":"R2-6-20210202","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1191\/0961203303lu354xx","article-title":"Clinical research helps elucidate the role of tumor necrosis factor alpha (TNF-alpha) in the pathogenesis of T1-mediated immune disorders: use of targeted immunotherapeutics as pathogenetic probes.","volume":"12","author":"Gottlieb","year":"2003","journal-title":"Lupus"},{"key":"R3-6-20210202","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1396-0296.2004.04044.x","article-title":"Infliximab.","volume":"17","author":"Winterfield","year":"2004","journal-title":"Dermatol Ther"},{"key":"R4-6-20210202","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/nm939","article-title":"TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases.","volume":"9","author":"Feldmann","year":"2003","journal-title":"Nat Med"},{"key":"R5-6-20210202","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nri802","article-title":"Development of anti-TNF therapy for rheumatoid arthritis.","volume":"2","author":"Feldmann","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"R6-6-20210202","first-page":"2132","article-title":"TRECID, TNFalpha related chronic inflammatory diseases-a new multiple diseases bridging concept [in German].","volume":"134","author":"Muller-Ladner","year":"2009","journal-title":"Dtsch Med Wochenschr"},{"key":"R7-6-20210202","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/art.23835","article-title":"Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: a literature review and potential mechanisms of action.","volume":"59","author":"Collamer","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R8-6-20210202","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1080\/09546630802441234","article-title":"Induction and exacerbation of psoriasis with TNF-blockade therapy: a review and analysis of 127 cases.","volume":"10","author":"Ko","year":"2009","journal-title":"J Dermatol Treat"},{"key":"R9-6-20210202","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1346-8138.2007.00312.x","article-title":"Psoriasiform and pustular eruption induced by infliximab.","volume":"34","author":"Takahashi","year":"2007","journal-title":"J Dermatol"},{"key":"R10-6-20210202","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1365-2230.2006.02315.x","article-title":"Flare and change of psoriasis morphology during the course of treatment with anti-tumor necrosis factor blockers.","volume":"32","author":"Goiriz","year":"2007","journal-title":"Clin Exp Dermatol"},{"key":"R11-6-20210202","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1365-2133.2007.07682.x","article-title":"Cutaneous side effects in patients with rheumatic diseases during application of tumor necrosis factor- antagonists.","volume":"156","author":"Lee","year":"2007","journal-title":"Br J Dermatol"},{"key":"R12-6-20210202","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/ard.2005.037424","article-title":"New onset or exacerbation of psoriatic skin lesions in patients with definite rheumatoid arthritis receiving tumour necrosis factor antagonists.","volume":"65","author":"Kary","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"R13-6-20210202","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1111\/j.1365-2133.2005.06977.x","article-title":"Infliximab can precipitate as well as worsen palmoplantar pustulosis: possible linkage to the expression of tumor necrosis factor- in the normal eccrine sweat duct?","volume":"153","author":"Michaelsson","year":"2005","journal-title":"Br J Dermatol"},{"key":"R14-6-20210202","first-page":"439","article-title":"Pustular psoriasis induced by infliximab.","volume":"3","author":"Thurber","year":"2004","journal-title":"J Drugs Dermatol"},{"key":"R15-6-20210202","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1177\/039463200902200331","article-title":"Psoriasis induced by infliximab in a patient suffering from Crohns disease.","volume":"22","author":"Manni","year":"2009","journal-title":"Int J Immunopathol Pharmacol"},{"key":"R17-6-20210202","first-page":"205","article-title":"Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis.","volume":"17","author":"Charles","year":"1999","journal-title":"J Immunol"},{"key":"R18-6-20210202","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/1529-0131(200001)43:1<38::AID-ANR6>3.0.CO;2-L","article-title":"Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis.","volume":"43","author":"Taylor","year":"2000","journal-title":"Arthritis Rheum"},{"key":"R19-6-20210202","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/1529-0131(199807)41:7<1258::AID-ART17>3.0.CO;2-1","article-title":"Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and inteleulin-1 in rheumatoid arthritis.","volume":"41","author":"Paleolog","year":"1998","journal-title":"Arthritis Rheum"},{"key":"R20-6-20210202","first-page":"1","article-title":"Immune-mediated skin lesions in patients treated with anti-tumour necrosis factor alpha inhibitors.","volume":"4","author":"Exarchou","year":"2009","journal-title":"Scand J Rheumatol"},{"key":"R21-6-20210202","first-page":"336","article-title":"Interstitial granulomatous dermatitis in a patient with rheumatoid arthritis on etanercept.","volume":"81","author":"Hu","year":"2008","journal-title":"Cutis"},{"key":"R22-6-20210202","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1136\/ard.2007.075663","article-title":"Granuloma annulare induced by anti-tumour necrosis factor therapy.","volume":"67","author":"Voulgari","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"R23-6-20210202","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1159\/000107622","article-title":"Cutaneous manifestations in inflammatory bowel diseases: eight cases of psoriasis induced by anti-tumor-necrosis-factor antibody therapy.","volume":"215","author":"Passarini","year":"2007","journal-title":"Dermatology"}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00000372-201008000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:01:20Z","timestamp":1618034480000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000372-201008000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0b013e3181cb3ff7","relation":{},"ISSN":["0193-1091"],"issn-type":[{"value":"0193-1091","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}